CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ALKS

ALKS 3831

Phase 3
Alkermes plc (ALKS)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
ALKSPhase 3

Olanzapine Phase 3 Est. Readout

ALKS 3831
Sep 2026~STALE
CT.gov
00%
Drug Information

Target Indication

Schizophrenia

Clinical Trial

NCT02694328

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.